Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023
Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023. Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...
Savvy on Glucagon, 4/19/23: With Tim Street on Glucagon and Microdosing
Glucagon me… n=1 experiments with microbolusing Glucagon by Tim Street for Diabettech.com, 4-5 April 2023. Part 1: Setting a Baseline Glucagon is a hormone that is produced by the alpha cells and is critical in maintaining glucose homeostasis. It works with the many...
Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?
Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet by Liam Davenport for MedScape.com, 14 April 2023. ChatGPT, the novel artificial intelligence (AI) tool that has attracted interest and controversy in seemingly equal measure, can provide clear and...
Savvy Updates 4/10/23: Abbott FreeStyle Libre Class 1 Recall, 2 T Cell Populations, Gut Health on TikTok, Pancreatic Endocrine & Exocrine Cells, “Counting Carbs is a Crapshoot!”
Abbott faces Class I recall of 4.2M glucose readers on battery fire risks by Peter Green for MedTechDive.com, 6 April 2023. Abbott has initiated a recall for readers for its FreeStyle Libre glucose monitoring systems, which are at risk of catching fire if improperly...
More Diabetes Blogs